发明名称 TRPV3 modulators
摘要 Disclosed herein are modulators of TRPV3 of Formula (I); wherein p is 1, 2, 3, or 4, and G1, X1, X2, X3, X4, X5, G2, Z1, Ra, Rb, and u are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also presented.
申请公布号 US8772499(B2) 申请公布日期 2014.07.08
申请号 US201213658355 申请日期 2012.10.23
申请人 AbbVie Inc. 发明人 Bayburt Erol K.;Clapham Bruce;Cox Phil B.;Daanen Jerome F.;Dart Michael J.;Gfesser Gregory A.;Gomtsyan Arthur;Kort Michael E.;Kym Philip R.;Schmidt Robert G.;Voight Eric A.
分类号 C07D213/00;C07D213/28;C07D211/74;C07D421/00;C07D401/00 主分类号 C07D213/00
代理机构 代理人
主权项 1. A compound according to Formula (I):or a salt thereof, wherein: Ra and Rb are each absent; u is 0; X3 is CH2; X4 is (CH2)m; X5 is (CH2)n; m and n are each 1; each Z1 group is a substituent on the X3 carbon atom of the ring containing X3, X4, and X5 and is independently halogen oxo C1-C4-alkyl, or —ORc; or two Z1 groups that are situated on the X3 carbon atom, together with the carbon atom to which they are attached, form a 5-membered monocyclic heterocycle ring comprising two oxygen ring atoms; Rc is hydrogen C1-C4-alkyl; p is 1 or 2; X1 is —OH and X2 is hydrogen; G1 is pyridinyl or pyrimidinyl; each of which is optionally substituted with 1, 2, or 3 substituents independently selected from the group consisting of halogen C1-C6-alkyl, C1-C6-haloalkyl, and N(Rgc)2; Rgc is hydrogen or C1-C6-alkyl; G2 is G2d; G2d is phenyl, pyridinyl, or pyrimidinyl; each of which is optionally substituted with 1, 2, or 3 substituents independently selected from the group consisting of halogen, —CN, C1-C6-alkyl, C1-C6-haloalkyl, and —ORf; and Rf is C1-C6-alkyl or C1-C6-haloalkyl.
地址 North Chicago IL US